Rituximab and alemtuzumab induce a nonclassic, caspase-independent apoptotic pathway in B-lymphoid cell lines and in chronic lymphocytic leukemia cells. - Stanglmaier, Michael; Reis, Simone; Hallek, Michael (Annals of Hematology, 2004)